(4S,5R)-5-phenylmethoxydithian-4-ol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4S,5R)-5-phenylmethoxydithian-4-ol
• 化学式: C₁₁H₁₄O₂S₂
• 分子量: 242.4
• InChiKey: NVSDXSHPRYTQHK-MNOVXSKESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  80.1
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• NUCLEOSIDE KINASE BYPASS COMPOSITIONS AND METHODS
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US20150315221A1

  公开（公告）日：2015-11-05

  The present invention relates to disulfide masked prodrug compounds, compositions and methods that are amenable to bioactivation by a reducing agent such as glutathione. Such disulfide based compounds, compositions, and methods can be useful, for example, in providing novel prodrugs for use as therapeutics.

  本发明涉及一种二硫化物掩蔽的前药化合物、组合物和方法，这些化合物、组合物和方法可通过还原剂如谷胱甘肽进行生物活化。这种基于二硫化物的化合物、组合物和方法可以用于提供新型前药，例如用作治疗药物。
• [EN] PHOSPHOPANTOTHENATE COMPOUNDS<br/>[FR] COMPOSÉS PHOSPHOPANTOTHÉNATE
  申请人：PROSPERO PHARMACEUTICALS LLC

  公开号：WO2017127417A1

  公开（公告）日：2017-07-27

  The invention relates to phosphopantothenate compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel compounds of the invention.

  本发明涉及磷酸泛酰丹参酸化合物及其制药制剂。本发明还涉及使用该新型化合物的治疗方法。
• US9624249B2
  申请人：——

  公开号：US9624249B2

  公开（公告）日：2017-04-18
• [EN] NUCLEOSIDE KINASE BYPASS COMPOSITIONS AND METHODS<br/>[FR] COMPOSITIONS ET MÉTHODES DE DÉRIVATION DE KINASES NUCLÉOSIDIQUES
  申请人：MERCK SHARP & DOHME

  公开号：WO2014088923A1

  公开（公告）日：2014-06-12

  The present invention relates to disulfide masked prodrug compounds, compositions and methods that are amenable to bioactivation by a reducing agent such as glutathione. Such disulfide based compounds, compositions, and methods can be useful, for example, in providing novel prodrugs for use as therapeutics. The compounds feature a conformationally restricted disulfide phosphotriester moiety to mask anionic charge. The compounds include a 1,2-dithigne moiety.